ATHX - アサ―シス （Athersys Inc.） アサ―シスATHXのチャート
ATHXの企業情報
| symbol | ATHx |
|---|---|
| 会社名 | Athersys Inc （アサ―シス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 アサーシス(Athersys Inc.)は主に再生医療の分野に焦点を当てた国際的なバイオ技術企業である。同社のマルチステム細胞療法（同種異系幹細胞製剤）は、リードプラットフォーム製品であり、後の段階の臨床開発段階にある。その臨床開発プログラムは、神経学的状態、心血管疾患、炎症性および免疫性障害、特定の肺疾患および多くの患者にとって注意の基準が限られているまたは不十分なその他の状態の治療に焦点を当てる。神経領域では、虚血性脳卒中による神経学的損傷の病歴を有する患者のマルチステム治療の可能性である第2相試験を評価した。同社は急性心筋梗塞（AMI）の病歴を有する患者に対するマルチステム細胞療法の投与のために米国で第II相臨床試験を開始した。 アサ―シスは、米国のバイオテクノロジ―企業。主に再生医療の分野に焦点を当て、炎症、免疫障害、神経学的疾患、心疾患、その他疾患の治療用の同種幹細胞製品を研究、開発、商品化する。主要なプラットフォ―ム製品は特許取得済の成人由来の量産可能な幹細胞製品MultiStem。本社はオハイオ州クリ―ブランド。 Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived 'off-the-shelf' stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular, and other critical care indications and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization. |
| 本社所在地 | 3201 Carnegie Avenue Cleveland OH 44115-2634 USA |
| 代表者氏名 | Gil Van Bokkelen ギルヴァンボケレン |
| 代表者役職名 | Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者 |
| 電話番号 | +1 216-431-9900 |
| 設立年月日 | 34973 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 66人 |
| url | www.athersys.com |
| nasdaq_url | https://www.nasdaq.com/symbol/athx |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -23.71700 |
| 終値（lastsale） | 2.11 |
| 時価総額（marketcap） | 292411550.03 |
| 時価総額 | 時価総額（百万ドル） 292.41160 |
| 売上高 | 売上高（百万ドル） 22.02600 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 239.05860 |
| 当期純利益 | 当期純利益（百万ドル） -23.56500 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Athersys Inc. revenues increased from $2.1M to $20.5M. Net loss decreased 73% to $3.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other expense net increase from $84K to $295K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.11 to -$0.02. |
ATHXのテクニカル分析
ATHXのニュース
Athersys to Announce First Quarter Financial Results on May 6 2022/04/29 13:00:00 Business Wire
CLEVELAND, Ohio--(BUSINESS WIRE)---- $ATHX #earningsdate--Athersys Q1 Conference Call to be Held Following Announcement of Phase 2/3 TREASURE Data in May.
Athersys - Hero Or Zero Opportunity 2022/04/18 14:56:34 Seeking Alpha
On 04/11/2022, Athersys shares spiked after a long downward slide, soon they were back on the skids. Read more about ATHX stock here.
Confounding stocks: Athersys, Inc. (NASDAQ:ATHX -3.14%), TechnipFMC plc (NYSE:FTI 1.39%) 2022/04/18 13:23:47 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Confounding stocks: Athersys, Inc. (NASDAQ:ATHX -3.14%), TechnipFMC plc (NYSE:FTI 1.39%) appeared first on Stocks Equity .
Wondrous stocks: Athersys, Inc. (NASDAQ:ATHX -3.14%), The Goldman Sachs Group, Inc. (NYSE:GS -0.10%) 2022/04/15 01:08:43 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Wondrous stocks: Athersys, Inc. (NASDAQ:ATHX -3.14%), The Goldman Sachs Group, Inc. (NYSE:GS -0.10%) appeared first on Stocks Equity .
Enthralling stocks: Athersys, Inc. (NASDAQ:ATHX -2.48%), ION Geophysical Corporation (NYSE:IO -13.12%) 2022/04/14 18:14:31 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Enthralling stocks: Athersys, Inc. (NASDAQ:ATHX -2.48%), ION Geophysical Corporation (NYSE:IO -13.12%) appeared first on Stocks Equity .
Athersys to Host Year-End 2021 Financial Results Call 2022/02/15 13:00:00 Business Wire
Athersys to Host Year-End 2021 Financial Results Call; New CEO, Daniel A. Camardo, and Management to Host Conference Call on March 15, 2022
Athersys Inc.s (NASDAQ:ATHX) Stock Price Rises 7.74% This Year: A Look At Likely Future Paths 2022/02/11 16:00:00 Stocks Register
Athersys Inc. (NASDAQ:ATHX) price on Thursday, February 10, rose 0.78% above its previous days close as an upside momentum from buyers pushed the stocks value to $0.97. A look at the stocks price movement, the close in the last trading session was $0.96, moving within a range at $0.925 and $1.03. The beta value (5-Year Athersys Inc.s (NASDAQ:ATHX) Stock Price Rises 7.74% This Year: A Look At Likely Future Paths Read More »
Athersys appoints veteran Daniel A. Camardo, to CEO post 2022/01/20 23:09:17 Seeking Alpha
Athersys (ATHX) appoints Daniel A. Camardo as the company''s CEO, effective February 14, 2022.Mr
Athersys: Near-Term Progress In Stem Cell Phase 3 Trials Could Multiply Shares In 2022 2022/01/20 19:34:07 Seeking Alpha
Athersys Inc Shares Fall 0.3% Below Previous 52-Week Low - Market Mover 2021/12/29 11:27:24 Kwhen Finance
Athersys Inc (ATHX) shares closed 0.3% lower than its previous 52 week low, giving the company a market cap of $232M. The stock is currently down 43.6% year-to-date, down 47.5% over the past 12 months, and down 38.3% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 25.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -254.3% The company's stock price performance over the past 12 months lags the peer average by -273.6%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Athersys appoints veteran Daniel A. Camardo, to CEO post 2022/01/20 23:09:17 Seeking Alpha
Athersys (ATHX) appoints Daniel A. Camardo as the company''s CEO, effective February 14, 2022.Mr
Athersys: Near-Term Progress In Stem Cell Phase 3 Trials Could Multiply Shares In 2022 2022/01/20 19:34:07 Seeking Alpha
Athersys Inc Shares Fall 0.3% Below Previous 52-Week Low - Market Mover 2021/12/29 11:27:24 Kwhen Finance
Athersys Inc (ATHX) shares closed 0.3% lower than its previous 52 week low, giving the company a market cap of $232M. The stock is currently down 43.6% year-to-date, down 47.5% over the past 12 months, and down 38.3% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 25.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -254.3% The company's stock price performance over the past 12 months lags the peer average by -273.6%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Athersys Inc.s Stock Price Soared Recently, But There Might Be Trouble Ahead 2021/12/22 13:00:00 Stocks Register
Athersys Inc. (NASDAQ:ATHX) traded at $0.98 at close of the session on Tuesday, 12/21/21, made a downward move of -1.59% on its previous days price. Looking at the stock we see that its previous close was $1.00 and the beta (5Y monthly) reads -1.58 with the days price range being $0.9663 $1.01. In terms Athersys Inc.s Stock Price Soared Recently, But There Might Be Trouble Ahead Read More »
Athersys, Inc. (NASDAQ:ATHX) Expected to Post Earnings of -$0.07 Per Share 2021/12/21 14:14:42 Transcript Daily
Analysts expect that Athersys, Inc. (NASDAQ:ATHX) will post earnings of ($0.07) per share for the current quarter, according to Zacks. Zero analysts have provided estimates for Athersys earnings. The lowest EPS estimate is ($0.09) and the highest is ($0.05). Athersys reported earnings of ($0.11) per share during the same quarter last year, which suggests a []